Susceptibilidade antimicrobiana de Neisseria meningitidis isoladas de casos de meningites no Brasil, 2006 a 2008
PDF (Português (Brasil))

Cómo citar

1.
Outeiro Gorla MC, de Cunto Brandileone MC. Susceptibilidade antimicrobiana de Neisseria meningitidis isoladas de casos de meningites no Brasil, 2006 a 2008. Bepa [Internet]. 30 de abril de 2009 [citado 24 de noviembre de 2024];6(64):15-7. Disponible en: https://periodicos.saude.sp.gov.br/BEPA182/article/view/38615

Resumen

 

 

PDF (Português (Brasil))

Citas

Centro de Vigilância Epidemiológica - CVE. Coordenador ia de Cont role de Doenças - CCD. Secretaria de Estado da Saúde da Saúde - SES. São Paulo: CVE [acesso em 16 outubro 2008]. Disponível em: http://www.cve.saude.sp.gov.br/htm/resp/ dm9004_cfeta.htm.

Taha MK, Vázquez JA, Hong E, Bennett DE, Bertrand S, Bukovski S, et al. Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis. Antimicrob Agents Chemother. 2007;51: 2784-92.

Plessis du M, Gottberg A von, Cohen C, Gouveia L, Klugman KP. Group for Enteric Re spi ra tor y and Mening e a l Di s e a s e Surveillance in South Africa (GERMS-SA). J Clin Microbiol. 2008;3208-14.

Apicella MA. Neisseria meningitidis. In: Mandell GL, Bennedet JE, Dolin R, editores. Principles and practice of infectious diseases. Philadelphia: Churchill Livengstone; 2000. p. 2228-41.

Jorgensen JH, Crawford AS, Fiebelkorn KR. Susceptibility of Neisseria meningitidis to 16 antimicrobial agents and characterization of resistance mechanisms affecting some agents. J Clin Microbiol. 2005;3162-71.

Alavi JB. Aplastic anemia associated with intravenous choramphenicol. Am J Hematol. 1983;15:375-9.

Galimand M, Gerbaud G, Guibourdeche M, Riou JY, Courvalin P. High-level chloramphenicol resistance in Neisseria meningitidis. N Engl J Med. 1998;339:868-74.

Carvalhanas TRMP, Pellini ACG, Gorla MCO. Infecção meningocócica. In: Lopes AC, editor. Tratado de clínica médica. São Paulo: Roca; 2006. v. 3, 3996-4015.

Faria SM, Farhat CK. Meningites bacterianas – diagnostico e conduta. J Pediatr. 1999; 75 (Supl 1):S46-S56.

Vázquez JA. The resistance of Neisseria meningitidis to the antimicrobial agents: an issue still in evolution. Rev Med Microbiol. 2001;12(1):39-45.

Vázquez JA. Resistance testing of meningococci: the recommendations of the European Monitoring Group on Meningococci. FEMS Microbiol Rev. 2007;31: 97-100.

Wu HM, Harcourt BH, Hatcher CP, Wei SC, Novak RT, Wang X, et al. Emergence of ciprofloxacin-resistant Neisseria meningitidis in North America. N Engl J Med. 2009;360: 886-92.

Singhal S, Purnapatre KP, Kalia V, Dube S, Nair D, Deb M, et al. Ciprofloxacin-resistant Neisseria meningitidis, Delhi, India. Emerg Infect Dis. 2007;13:1614–16.

Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved Standard - seventh informational supplement. In: CLSI document M7-A7. Wayne, PA: Clinical and Laboratory Standards Institute, 2006.

Performance Standards for Antimicrobial Susceptibility Testing: eighteenth informational supplement. In: CLSI document M100-S18. Wayne, PA: Clinical and Laboratory Standards Institute, 2008.

Creative Commons License

Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.

Derechos de autor 2009 Maria Cecília Outeiro Gorla, Maria Cristina de Cunto Brandileone

Descargas

Los datos de descargas todavía no están disponibles.

Métricas

Cargando métricas ...